These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32048711)

  • 21. Oncological and reproductive outcomes after fertility-sparing surgery in patients with seromucinous borderline ovarian tumor: Results of a large retrospective study.
    Wang D; Jia S; Jia C; Cao D; Yang J; Yang J; Xiang Y
    Gynecol Oncol; 2022 Jun; 165(3):446-452. PubMed ID: 35469684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors.
    Vancraeynest E; Moerman P; Leunen K; Amant F; Neven P; Vergote I
    Int J Gynecol Cancer; 2016 Oct; 26(8):1399-406. PubMed ID: 27465897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of ovarian conservation and fertility preservation in advanced borderline ovarian tumors.
    Helpman L; Beiner ME; Aviel-Ronen S; Perri T; Hogen L; Jakobson-Setton A; Ben-Baruch G; Korach J
    Fertil Steril; 2015 Jul; 104(1):138-44. PubMed ID: 25956371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unilateral cystectomy and serous histology are associated with relapse in borderline ovarian tumor patients with fertility-sparing surgery: a systematic review and meta-analysis.
    Li N; Ming X; Li Z
    Arch Gynecol Obstet; 2020 Nov; 302(5):1063-1074. PubMed ID: 32748055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.
    Schilder JM; Thompson AM; DePriest PD; Ueland FR; Cibull ML; Kryscio RJ; Modesitt SC; Lu KH; Geisler JP; Higgins RV; Magtibay PM; Cohn DE; Powell MA; Chu C; Stehman FB; van Nagell J
    Gynecol Oncol; 2002 Oct; 87(1):1-7. PubMed ID: 12468335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
    Vasconcelos I; Darb-Esfahani S; Sehouli J
    BJOG; 2016 Mar; 123(4):498-508. PubMed ID: 26705090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
    Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
    Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. An analysis from the MITO14 study database.
    Falcone F; Breda E; Ferrandina G; Malzoni M; Perrone AM; Cormio G; Di Donato V; Frigerio L; Mangili G; Raspagliesi F; Festi A; Scibilia G; Biglia N; Sorio R; Vizza E; Losito NS; Greggi S
    Gynecol Oncol; 2021 Jun; 161(3):825-831. PubMed ID: 33781554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy and obstetric outcomes after fertility-sparing management of endometrial cancer and atypical hyperplasia: a multicentre cohort study.
    Vasileva R; Wohrer H; Gaultier V; Bucau M; Courcier H; Ben Miled S; Gonthier C; Koskas M
    Hum Reprod; 2024 Jun; 39(6):1231-1238. PubMed ID: 38719783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncological and Reproductive Outcomes After Fertility-Sparing Surgery for Stage I Mucinous Ovarian Carcinoma.
    Lin W; Cao D; Shi X; You Y; Yang J; Shen K
    Front Oncol; 2022; 12():856818. PubMed ID: 35860580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound-Guided Laparoscopic Ovarian Wedge Resection in Recurrent Serous Borderline Ovarian Tumours.
    Jones BP; Saso S; Farren J; El-Bahrawy M; Ghaem-Maghami S; Smith JR; Yazbek J
    Int J Gynecol Cancer; 2017 Nov; 27(9):1813-1818. PubMed ID: 28763365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and fertility outcomes after the conservative treatment of endometrioid borderline ovarian tumours.
    Jia SZ; Zhang JJ; Liang ZY; Yang JJ; Xiang Y; Jia CW; Leng JH
    BMC Cancer; 2018 Nov; 18(1):1160. PubMed ID: 30470202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obstetric outcomes after conservative management of ovarian borderline tumors in women of reproductive age: A single center experience.
    Sobiczewski P; Piatek S; Michalski W; Kupryjańczyk J; Maciejewski T; Ołtarzewski M; Bidzinski M
    Eur J Obstet Gynecol Reprod Biol; 2022 Feb; 269():126-131. PubMed ID: 34998079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of borderline ovarian tumours.
    Gershenson DM
    Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():49-59. PubMed ID: 27780698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncological and Reproductive Outcomes of Cystectomy Compared with Unilateral Salpingo-Oophorectomy as Fertility-Sparing Surgery in Patients with Apparent Early Stage Pure Immature Ovarian Teratomas.
    Wang D; Zhu S; Jia C; Cao D; Yang J; Xiang Y
    Ann Surg Oncol; 2021 Oct; 28(11):6684-6693. PubMed ID: 33772392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second fertility-sparing surgery and fertility-outcomes in patients with recurrent borderline ovarian tumors.
    Wang L; Zhong Q; Tang Q; Wang H
    Arch Gynecol Obstet; 2022 Oct; 306(4):1177-1183. PubMed ID: 35396974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncologic and obstetric outcomes of early-stage epithelial ovarian cancer patients who underwent fertility-sparing surgery: A retrospective study.
    Ayhan A; Tunç M; Atasoy Karakaş L; Tekelioğlu T; Haberal Reyhan AN; Önalan G; Kuşçu E
    Int J Gynaecol Obstet; 2023 Aug; 162(2):711-717. PubMed ID: 36825554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrences and fertility after endometrioma ablation in women with and without colorectal endometriosis: a prospective cohort study.
    Roman H; Quibel S; Auber M; Muszynski H; Huet E; Marpeau L; Tuech JJ
    Hum Reprod; 2015 Mar; 30(3):558-68. PubMed ID: 25574030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncologic and reproductive outcomes of cystectomy as a fertility-sparing treatment for early-stage epithelial ovarian cancer.
    Kajiyama H; Suzuki S; Niimi K; Tamauchi S; Kawai M; Nagasaka T; Shibata K; Kikkawa F
    Int J Clin Oncol; 2019 Jul; 24(7):857-862. PubMed ID: 30771039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.